Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Marston Linehan

Showing results (231-240 of 541) with videos related to

Pageof 55
Sort By:
Urologic Oncology|December 11, 2020
Long term outcomes for patients with von Hippel-Lindau and Pheochromocytoma: defining the role of active surveillanceThomas Sanford, Patrick T Gomella, Rashid Siddiqui, et al.
Urologic Oncology|December 27, 2008
Immunohistochemical basis for adjuvant anti-angiogenic targeted therapy for renal carcinoid: initial case reportDavid S Finley, Navneet Narula, Vladimir A Valera, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|June 29, 2023
Complications after Nephron-sparing Interventions for Renal Tumors: Imaging Findings and ManagementAditi Chaurasia, Shiva Singh, Fatemeh Homayounieh, et al.
Radiology|May 19, 2020
Clear Cell Renal Cell Carcinoma Growth Correlates with Baseline Diffusion-weighted MRI in Von Hippel-Lindau DiseaseFaraz Farhadi, Moozhan Nikpanah, Anna K Paschall, et al.
Oncotarget|August 24, 2015
Tonantzitlolone cytotoxicity toward renal cancer cells is PKCθ- and HSF1-dependentCarole Sourbier, Bradley T Scroggins, Philip Z Mannes, et al.
Cancer & Metabolism|August 11, 2020
Fumarate hydratase-deficient renal cell carcinoma cells respond to asparagine by activation of the unfolded protein response and stimulation of the hexosamine biosynthetic pathwayRony Panarsky, Daniel R Crooks, Andrew N Lane, et al.
Abdominal Radiology (New York)|September 15, 2025
Characterization of complex renal cysts in hereditary leiomyomatosis and renal cell cancerUsing magnetic resonance based qualitative featuresAli Sheikhy, Aryan Zahergivar, Mahshid Golagha, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 8, 2025
Estimated blood loss to urine output ratio during partial nephrectomy as a predictor of postoperative acute kidney injury in a hereditary renal cancer-enriched populationLauren Loebach, Ruben Blachman-Braun, Milan H Patel, et al.
Cancer|October 5, 2002
Prospective analysis of circulating endostatin levels in patients with renal cell carcinomaAndrew L Feldman, H Richard Alexander, James C Yang, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 1, 2013
Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangementMinghao Zhong, Paul Weisman, Bing Zhu, et al.
Pageof 55

Showing results (231-240 of 541) with videos related to

Sort By:
Pageof 55
Urologic Oncology|December 11, 2020
Long term outcomes for patients with von Hippel-Lindau and Pheochromocytoma: defining the role of active surveillanceThomas Sanford, Patrick T Gomella, Rashid Siddiqui, et al.
Urologic Oncology|December 27, 2008
Immunohistochemical basis for adjuvant anti-angiogenic targeted therapy for renal carcinoid: initial case reportDavid S Finley, Navneet Narula, Vladimir A Valera, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|June 29, 2023
Complications after Nephron-sparing Interventions for Renal Tumors: Imaging Findings and ManagementAditi Chaurasia, Shiva Singh, Fatemeh Homayounieh, et al.
Radiology|May 19, 2020
Clear Cell Renal Cell Carcinoma Growth Correlates with Baseline Diffusion-weighted MRI in Von Hippel-Lindau DiseaseFaraz Farhadi, Moozhan Nikpanah, Anna K Paschall, et al.
Oncotarget|August 24, 2015
Tonantzitlolone cytotoxicity toward renal cancer cells is PKCθ- and HSF1-dependentCarole Sourbier, Bradley T Scroggins, Philip Z Mannes, et al.
Cancer & Metabolism|August 11, 2020
Fumarate hydratase-deficient renal cell carcinoma cells respond to asparagine by activation of the unfolded protein response and stimulation of the hexosamine biosynthetic pathwayRony Panarsky, Daniel R Crooks, Andrew N Lane, et al.
Abdominal Radiology (New York)|September 15, 2025
Characterization of complex renal cysts in hereditary leiomyomatosis and renal cell cancerUsing magnetic resonance based qualitative featuresAli Sheikhy, Aryan Zahergivar, Mahshid Golagha, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 8, 2025
Estimated blood loss to urine output ratio during partial nephrectomy as a predictor of postoperative acute kidney injury in a hereditary renal cancer-enriched populationLauren Loebach, Ruben Blachman-Braun, Milan H Patel, et al.
Cancer|October 5, 2002
Prospective analysis of circulating endostatin levels in patients with renal cell carcinomaAndrew L Feldman, H Richard Alexander, James C Yang, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 1, 2013
Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangementMinghao Zhong, Paul Weisman, Bing Zhu, et al.
Pageof 55